Source: BIOPORTFOLIO

ELC: ELC Group expands into product development

Regulatory affairs services provider ELC Group is expanding into the pharmaceutical development market with the creation of an extensive product portfolio targeting a range of therapeutic areas.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

CEO

Marco Rubinstein

CEO Approval Rating

- -/100